New dressing uses nitric oxide to fight diabetic foot ulcers
NCT ID NCT07438951
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study is testing a new dressing called ConvaNiox that releases nitric oxide to help heal diabetic foot ulcers. About 102 adults with diabetes and a foot ulcer will receive the dressing along with standard care. Researchers will measure how much the wound shrinks over time and how often it closes completely.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
nitric oxide generating dressing (ConvaNiox)
What this could lead to
If successful, this dressing could become a new option to help diabetic foot ulcers heal faster and reduce complications.
What could go wrong
This is an early observational study with only 102 participants, so results may not apply to everyone. The dressing may not speed up healing significantly.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETIC FOOT ULCERS (DFUS) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••